Stock showcase

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by hollyhunter, Nov 12, 2017.

  1. hollyhunter

    hollyhunter Member

    Joined:
    Apr 13, 2016
    Messages:
    60
    Likes Received:
    10
    SBGI’s strengths can be seen in its strong growth and robust profitability compared with its peers. Its revenue and net income have increased over several years. Technical indicators signal the bullish signs, as there is a bullish cross in MACD and Stochastic Oscillator, RSI (14) stands at 57.83 with positive bias. We rate Sinclair Broadcast Group, Inc. (SBGI) a STRONG BUY.

    HSNI’s strengths can be seen in its strong profitability and robust efficiency compared with its peers. Technical indicators signal the bullish signs, as there is a bullish cross in MACD and Stochastic Oscillator, RSI (14) stands at 61.93 with positive bias. We rate HSN, Inc. (HSNI) a STRONG BUY.
    http://www.stoxline.com/showcase.php
     
  2. hollyhunter

    hollyhunter Member

    Joined:
    Apr 13, 2016
    Messages:
    60
    Likes Received:
    10
    Stock showcase for Nov.26- Dec.01: ABUS, CHL.

    Arbutus Biopharma Corporation, a biopharmaceutical company, engages in discovering, developing, and commercializing a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). The companys lead candidate is ARB-1467, which is in a Phase II trial to eliminate HBV surface antigen expression in patients chronically infected with HBV. Its product candidates also comprise ARB-1740, a pan-genotypic second-generation siRNA therapeutic in Phase II multi-dose study in Hepatitis B e antigen-chronic HBV patients; and AB-423, a core protein/capsid assembly inhibitor in Phase I clinical trial as an oral therapeutic for the treatment of chronic HBV infection. In addition, the company has various research programs for the discovery and development of proprietary HBV candidates, including oral surface antigen inhibitors, cccDNA targeting agents, and immunomodulators. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Burnaby, Canada.

    China Mobile Limited, an investment holding company, provides mobile telecommunications and related services in Mainland China and Hong Kong. It offers voice services, including local calls; domestic and international long distance calls and roaming services; and voice value-added services, such as caller identity display, call waiting, conference calls, and others. The company also provides wireless Internet service, as well as digital applications, including music, video, reading, gaming, and animation; and wireline broadband services. In addition, it offers dedicated line services to corporate customers in a range of industry sectors; and basic corporate communication products, such as corporate VPMN and SMS, as well as tailor made solutions. The company was formerly known as China Mobile (Hong Kong) Limited and changed its name to China Mobile Limited in May 2006. The company was incorporated in 1997 and is based in Central, Hong Kong. China Mobile Limited is a subsidiary of China Mobile Hong Kong (BVI) Limited.
    http://www.stoxline.com/showcase.php
     

Share This Page